Stallion Uranium Increases Private Placement to $1.45 Million

In This Article:

Stallion Uranium Corp.
Stallion Uranium Corp.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

VANCOUVER, British Columbia, April 09, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that, further to its news release dated April 1, 2025 and due to increased investor interest, the Company has increased the non-brokered private placement from 13,000,000 common shares (the “Shares”) to up to 14,500,000 Shares at a price of CDN$0.10 per Share for gross proceeds of up to CDN$1,450,000 (the “Offering”).

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions (“NI 45-106”), up to 13,500,000 Shares (the “LIFE Securities”) will be offered pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the “Listed Issuer Financing Exemption”). The Shares issued issuable pursuant to the sale of the LIFE Securities shall be freely tradeable under applicable Canadian securities legislation if sold to purchasers resident in Canada.

Up to 1,000,000 Shares (the “Non-LIFE Securities”) will be offered by way of the “accredited investor” exemption under NI 45-106 in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the U.S. Securities Act. The Shares issuable pursuant to the sale of the Non-LIFE Securities will be subject to a hold period ending on the date that is four months plus one day following the closing date of the Offering under applicable Canadian securities laws.

The Company may pay finder’s fees and/or commissions to eligible persons in connection with the Offering in accordance with applicable securities laws and the policies of the TSX Venture Exchange (the “TSX-V”).

The net proceeds of the Offering will be used for corporate purposes and exploration expenditures on the Company’s properties.

Closing of the Offering is subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX-V. Closing of the Offering is anticipated to take place on or before April 18, 2025 (the “Closing Date”).

The Offered securities described in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any United States state securities laws, and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons absent registration or an exemption from registration requirements. This news release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities in the United States, not in any other jurisdiction in which such offer, solicitation or sale would be unlawful.